Remikiren
CARDIOVASCULAR SYSTEM
Also known as: Ro 42-5892, Ro-42-5892
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Remikiren is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including REN.
- Molecular targets: REN (1 listed in DrugCentral).
- ATC code: C09XA01 (Renin-inhibitors).
- Molecular formula: C33H50N4O6S; molecular weight 630.85 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C09XA01 | CARDIOVASCULAR SYSTEM › AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM › OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM › Renin-inhibitors |
Chemical structure
| Molecular formula | C33H50N4O6S |
|---|---|
| Molecular weight | 630.85 g/mol |
| CAS number | 126222-34-2 |
| InChIKey | UXIGZRQVLGFTOU-VQXQMPIVSA-N |
| PubChem CID | 6324659 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Remikiren work?
Its molecular targets in DrugCentral include REN (inhibitor).
What is the chemical formula of Remikiren?
Remikiren has the molecular formula C33H50N4O6S and a molecular weight of 630.85 g/mol.
Browse: all drugs starting with R · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4696 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL31601 — compound record and bioactivity
- PubChem CID 6324659 — chemical identifiers
- DrugBank DB00212 — drug record
- FDA UNII LC7FBL96A4 — substance identity
- UniProt P00797 (REN) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.